Skip to main content

Management of Cancer Pain

  • Chapter
  • First Online:
Book cover Essentials of Pain Management

Abstract

Cancer is the second leading cause of death in the United States after heart diseases. Center of Disease Control estimated number of cancer deaths in 2005 to 559,312. Cancer constitutes 22.8% of the total death in the United States. Lung cancer is the most common fatal cancer in men (31%), followed by colon and rectum (10%), and prostate (9%). In women, lung (26%), breast (15%), and colon and rectum (10%) are the leading causes of cancer death. Most patients with cancer have pain. Cancer pain can develop from tumor invasion, musculoskeletal pain, visceral pain, radiation treatment effect, or neuropathy from chemotherapy. The incidence of pain in cancer patients receiving active treatment for early disease is about 20–25%. The incidence of pain in cancer patient with advanced disease is about 90%. More than 50% of patients with cancer pain have only one or two locations of pain. This fact usually gives the opportunity for interventional pain doctors to help patients with pain. Many cancer patients present with a combination of pain types such as visceral and somatic pain. Up to 90% of cancer pain patients respond well to medical treatment. A high percentage of the remaining individuals also respond well to interventional pain techniques (Portenoy 1989).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abram SE, ed. Pain management. In: Miller RD, editor. Atlas of anesthesia. Philadelphia, PA: Churchill Livingstone; 1998. Vol. 6.

    Google Scholar 

  • Benedetti C, Brock C, Cleeland C, et al. NCCN practice guidelines for cancer pain. Oncology 2000;14:135–50.

    PubMed  CAS  Google Scholar 

  • Bennett G, Burchiel K, Buchser E, et al. Clinical guidelines for intraspinal infusion: report of an expert panel. J Pain Symptom Manage. 2000;20:S37–S43.

    Article  PubMed  CAS  Google Scholar 

  • Berland D. Pain management in patients with advanced cancer. Ann Intern Med. 2000;132:593.

    PubMed  CAS  Google Scholar 

  • Burton AW, Driver LC, Mendoza TR, et al. Oral transmucosal fentanyl citrate in the outpatient management of severe cancer pain crises. Clin J Pain. 2004a;20:195–97.

    Article  PubMed  Google Scholar 

  • Burton AW, Rajagopal A, Hassenbusch SJ, et al. Reduction in pain and oral opioid intake after intrathecal pump implantation. In: Program and abstracts of the International Association for the Study of Pain 10th World Congress on Pain, August 17–22, 2002, San Diego, CA.

    Google Scholar 

  • Burton AW, Rajagopal A, Shah HN, et al. Epidural and intrathecal analgesia is effective in treating refractory cancer pain. Pain Med. 2004b;5:239–47.

    Article  PubMed  Google Scholar 

  • Carr DB, Goudas LC, Balk EM, et al. Evidence report on the treatment of pain in cancer patients. J Nat Cancer Inst Monogri. 2004;32:23–31.

    Article  Google Scholar 

  • Cherny NI. The management of cancer pain. CA Cancer J Clin. 2000;50:70–116. Abstract

    Article  PubMed  CAS  Google Scholar 

  • Davies DD. Incidence of major complications of neurolytic coeliac plexus block. J R Soc Med. 1993;86:264–266.

    PubMed  CAS  Google Scholar 

  • de Leon-Casasola OA. Critical evaluation of chemical neurolysis of the sympathetic axis for cancer pain. Cancer Control 2000;7:142–8.

    PubMed  Google Scholar 

  • Doggrell SA. Intrathecal ziconotide for refractory pain. Expert Opin Invest Drugs. 2004;13:875–77.

    Article  CAS  Google Scholar 

  • Eisenach JC, Du Pen S, Dubois M, et al. Epidural clonidine analgesia for intractable cancer pain. The Epidural Clonidine Study Group. Pain 1995;61:391–99.

    Article  PubMed  CAS  Google Scholar 

  • Eisenberg E, Carr DB, Chalmers TC. Neurolytic celiac plexus block for treatment of cancer pain: a meta-analysis. Anesth Analg. 1995;80:290–5.

    Article  PubMed  CAS  Google Scholar 

  • Erdine S, Talu GK. Cost effectiveness of implantable devices versus tunneled catheters. Curr Rev Pain. 1998;2:157–62.

    Google Scholar 

  • Fukshansky M, Are M, Burton AW. The role of opioids in cancer pain management. Pain Pract. 2005;5:43–54.

    Article  PubMed  Google Scholar 

  • Gilmer-Hill HS, Boggan JE, Smith KA, et al. Intrathecal morphine delivered via subcutaneous pump for intractable cancer pain: a review of the literature. Surg Neurol. 1999;51:12–5.

    Article  PubMed  CAS  Google Scholar 

  • Jacox AK, Carr DB, Payne R, et al. Management of cancer pain: clinical practice guideline No. 9. Rockville, MD: Agency for Healthcare Policy and Research, US Department of Health and Human Services, Public Health Service; 1994: AHCPR Publication No. 94-0592.

    Google Scholar 

  • Miguel R. Interventional treatment of cancer pain: the fourth step in the World Health Organization analgesic ladder? Cancer Control 2000;7:149–56.

    PubMed  CAS  Google Scholar 

  • Patt RB. Cancer pain. Philadelphia, PA: Lippincott; 1993.

    Google Scholar 

  • Plancarte R, de Leon-Casasola OA, El-Helay M, et al. Neurolytic superior hypogastric plexus block for chronic pelvic pain associated with cancer. Reg Anesth. 1997;22:562–8.

    PubMed  CAS  Google Scholar 

  • Portenoy RK. Cancer pain: epidemiology and syndromes. Cancer 1989;63(11 suppl): 2298–307.

    Article  PubMed  CAS  Google Scholar 

  • Shah HN, Burton AW, Mendoza T, et al. Neurolytic blockade of the splanchnic nerves block relieves refractory pain associated with upper abdominal malignancy. In: Program and Abstracts of the Annual Meeting of the American Society of Anesthesiologists; October 11–15, 2003, San Francisco, CA; Abstract A1024.

    Google Scholar 

  • Stoelting RK, Miller RD. Spinal and epidural anesthesia. In: Stoelting RK, Miller RD, editors. Basics of anesthesia. Philadelphia, PA: Churchill Livingstone; 2000. pp. 168–95.

    Google Scholar 

  • Waldman SD. Interventional pain management. Phildelphia, PA: Saunders; 2001.

    Google Scholar 

  • Wong GY, Brown DL. Celiac plexus block for cancer pain. In: Utney W, editor. Techniques in regional anesthesia and pain management. Vol. 1. Philadelphia, PA: W.B. Saunders; 1997.

    Google Scholar 

  • World Health Organization. Cancer pain relief and palliative care: report of a WHO expert committee. WHO Tech Rep Ser. 1990;804:1–73.

    Google Scholar 

  • Zech DFJ, Grond S, Lynch J, et al. Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain 1995;63:65–76.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Atallah, J.N. (2011). Management of Cancer Pain. In: Vadivelu, N., Urman, R., Hines, R. (eds) Essentials of Pain Management. Springer, New York, NY. https://doi.org/10.1007/978-0-387-87579-8_28

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-87579-8_28

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-87578-1

  • Online ISBN: 978-0-387-87579-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics